Top 50 Health Care VC Funds & Investors in United States (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Alumni Ventures
VC Fund
|
143 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.4M–$79M |
|
Innova Memphis
VC Fund
|
133 | United States, Argentina, United Kingdom | Seed, Pre-Seed | Health Care, Medical, Medical Device | $25k–$1.7M |
|
General Catalyst
VC Fund
|
126 | United States, United Kingdom, India | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.6M–$135M |
|
ARCH Venture Partners
VC Fund
|
124 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.8M–$250M |
|
SOSV
VC Fund
|
123 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Right Side Capital Management
VC Fund
|
115 | United States, Canada, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, SaaS, Health Care | $18k–$2M |
|
Khosla Ventures
VC Fund
|
111 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
New Enterprise Associates
VC Fund
|
102 | United States, India, United Kingdom | Series A, Series B, Series C | Software, Health Care, Biotechnology | $5.3M–$103M |
|
StartUp Health
VC Fund
|
102 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Gaingels
VC Fund
|
97 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.4M–$100M |
|
F-Prime
VC Fund
|
92 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $9.2M–$130M |
|
Andreessen Horowitz
VC Fund
|
92 | United States, United Kingdom, Brazil | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.5M–$107M |
|
Rock Health Capital
VC Fund
|
91 | United States, Denmark | Seed, Series A, Series B | Health Care, Software, Medical | $20k–$63M |
|
OrbiMed
VC Fund
|
91 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
Alexandria Venture Investments
VC Fund
|
88 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$150M |
|
Polaris Partners
VC Fund
|
84 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $4.5M–$107M |
|
Connecticut Innovations
VC Fund
|
80 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $200k–$25M |
|
Atlas Venture
VC Fund
|
78 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.2M–$115M |
|
First Round Capital
VC Fund
|
75 | United States, Canada, India | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $1.1M–$60M |
|
Lux Capital
VC Fund
|
75 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.8M–$150M |
|
BoxGroup
VC Fund
|
73 | United States, Mexico, Canada | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.6M–$90M |
|
Versant Ventures
VC Fund
|
71 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$108M |
|
Google Ventures
VC Fund
|
71 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1M–$107M |
|
Canaan Partners
VC Fund
|
70 | United States, United Kingdom, Israel | Series A, Series B, Series C | Software, Biotechnology, Health Care | $5M–$75M |
|
SV Aangel
VC Fund
|
70 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Internet | $1M–$107M |
|
Portfolia
VC Fund
|
67 | United States, Canada, Romania | Seed, Series A, Series B | Health Care, Biotechnology, Software | $347k–$59M |
|
Founders Fund
VC Fund
|
66 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.5M–$105M |
|
Third Rock Ventures
VC Fund
|
66 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $11M–$150M |
|
TEDCO
VC Fund
|
66 | United States, Canada, United Kingdom | Seed, Grant, Pre-Seed | Health Care, Software, Biotechnology | $25k–$2.5M |
|
5AM Ventures
VC Fund
|
64 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $13M–$110M |
|
BioAdvance
VC Fund
|
63 | United States, Canada | Seed, Series A | Biotechnology, Health Care, Medical | $200k–$40M |
|
MPM Capital
VC Fund
|
61 | United States, Canada, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $9M–$125M |
|
8VC
VC Fund
|
58 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Health Care, Artificial Intelligence | $2.7M–$175M |
|
Wavemaker 360
VC Fund
|
58 | United States, United Kingdom, Canada | Seed, Series A | Health Care, Medical, Medical Device | $700k–$16M |
|
RA Capital Management
VC Fund
|
57 | United States, United Kingdom, Canada | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Therapeutics | $26M–$235M |
|
HealthTech Capital
VC Fund
|
57 | United States, Canada | Seed, Series A, Convertible Note | Health Care, Medical Device, Medical | $1M–$15M |
|
Rev1 Ventures
VC Fund
|
57 | United States, Germany | Seed, Series A | Software, Health Care, Information Technology | $192k–$18M |
|
Sante Ventures
VC Fund
|
54 | United States, Canada, Japan | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.9M–$80M |
|
True Ventures
VC Fund
|
54 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $1.2M–$50M |
|
KdT Ventures
VC Fund
|
54 | United States, India, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $2.6M–$175M |
|
Greycroft
VC Fund
|
53 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, E-Commerce | $1.5M–$79M |
|
Bessemer Venture Partners
VC Fund
|
53 | United States, India, Israel | Series B, Series A, Series C | Software, Information Technology, SaaS | $5M–$100M |
|
Felicis
VC Fund
|
53 | United States, Canada, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, SaaS | $1.2M–$76M |
|
Pear VC
VC Fund
|
52 | United States, Brazil, Colombia | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $500k–$35M |
|
Great Oaks Venture Capital
VC Fund
|
52 | United States, United Kingdom, Spain | Seed, Series A, Series B | E-Commerce, Software, Health Care | $750k–$42M |
|
Flare Capital Partners
VC Fund
|
51 | United States, India | Series A, Seed, Series B | Health Care, Medical, Wellness | $1.8M–$125M |
|
Hatteras Venture Partners
VC Fund
|
50 | United States, Canada | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $5M–$90M |
|
Asset Management Ventures (AMV)
VC Fund
|
50 | United States, Cyprus, Ireland | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $500k–$35M |
|
DCVC
VC Fund
|
50 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $1.5M–$130M |
|
Kleiner Perkins
VC Fund
|
50 | United States, China, United Kingdom | Series B, Series A, Series C | Software, Health Care, Information Technology | |
| Access all 13307 VC funds in United States Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 1429
- Round size: Seed $1.4M–$10M; Series A $5.2M–$37M; Series B $12M–$79M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Verishop — Shop designer clothing, shoes, bags and accessories from top Italian boutiques. Discover the latest luxury fashion at competitive prices with global shipping.
- Lincode — The #1 business challenge that manufacturers identify is quality management. As new manufactured products continue to enter the market and consumer expectations shift faster than ever, factories are looking to improve their quality systems while scaling operations and cutting costs. At Lincode, we enable manufacturers to improve the speed, accuracy, and data tracking capabilities of their quality inspection systems at scale.
- Arda Therapeutics — Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA.
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: United States, Argentina, United Kingdom
Investor stats
- Total investments: 251
- Round size: Seed $50k–$1.7M; Pre-Seed $25k–$1.3M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- HerdDogg — HerdDogg is passionate about livestock. Its innovative data platform sits at the intersection of agtech, the internet of things, and global food security. Our patented DoggTags and DoggBone, together with our Animal Traceability Platform, help producers make more money from every animal they raise. The HerdDogg system enables animal tracking,welfare monitoring and traceability in an easy-to-use application. For more information, visit herddogg.com.
- Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
- Rescue Forensics — Customer service is our #1 priority. Get a premium domain for your website today. Financing available.
Investing in powerful, positive change that endures
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 1593
- Round size: Seed $1.6M–$18M; Series A $6M–$70M; Series B $12M–$135M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- OM1 — In healthcare, results really do matter. We're measuring and forecasting outcomes at a whole new level - transforming population data into precision health using real-world data and AI
- Render — Deploy and scale any app or agent from your first user to your billionth. Build faster on intuitive cloud infrastructure for the modern web.
- Section4 — Section4 membership gives you unlimited classes with the best minds in business.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 388
- Round size: Series A $7.8M–$212M; Series B $13M–$250M; Series C $15M–$175M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
- Arbor Biotechnologies — Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Using artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, we are accelerating the discovery of proteins for improving human health and sustainability.
- Protillion Biosciences — Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Systematic Pre-Seed Startup Capital
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 723
- Round size: Seed $18k–$2M; Pre-Seed $50k–$450k; Convertible Note $50k–$500k
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
- Vidrovr — Vidrovr develops multimodal computer vision and machine learning systems to index, tag, and understand video. It processes videos with specific domain constraints, such as in sports, government, and media verticals. Its technology enables its users to search an indexed video corpus and retrieve content inside videos and link it to other media likephotos and text.The company Integrates social media to enable direct interactions between multimedia content. Vidrovr was founded in 2016 and is headquartered in New York.
- Dealpad — Transform your sales team with our cutting-edge AI Buyer Enablement Platform. Win more deals, repeatedly.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1085
- Round size: Seed $2M–$17M; Series A $5.5M–$44M; Series B $10M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $557M in 2022
Portfolio highlights
- Fundbox — Fundbox offers fast, easy access to business financing, up to $150,000. Learn how our line of credit and term loan options can unlock growth for your business.
- Even — Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.
- Loop — Loop Health is bringing ease and choice to patients seeking major medical treatments. We've brought together family physicians, top specialists, and leading hospitals in Pune – to provide options, transparency, and ease to patients and their families. Loop Coordinators help patients match with a doctor, compare treatment costs, get secondopinions, and complete admission formalities – removing the stress and making lives easier for the patient and their families.
Foundational partners to ambitious founders at every stage of company-building.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1539
- Round size: Series A $5.3M–$60M; Series B $10M–$80M; Series C $13M–$103M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $2.8B in 2022
Portfolio highlights
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
- Allay Therapeutics — SUPPORTING PATIENTS THROUGH EVERY PHASE OF RECUPERATION The first technology designed to deliver weeks of localized pain management
- Regulus Therapeutics — Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteinsbut instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 194
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 755
- Round size: Seed $1.4M–$8M; Series A $6M–$40M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Paxton — Regulatory Intelligence, with the speed of Generative AI.
- Limbic — Limbic creates neuroscience of emotion packaged for developers. With just a few lines of code, anyone can make their app emotionally intelligent. Use the SDK to build products that interact with your user as naturally as interactions between two humans.
- Sharper Sense — Neuromodulation for Clear Senses
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 423
- Round size: Series A $9.2M–$87M; Series B $16M–$130M; Series C $22M–$115M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Axle Health — Axle Health provides scheduling and workforce management software to help home healthcare and hospice providers improve their clinician productivity.
- CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
- RightHand Robotics — RightHand Robotics offers advanced robotic piece-picking technology for efficient and predictable order fulfillment. Contact us today to learn how.
Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Brazil
Investor stats
- Total investments: 1630
- Round size: Seed $1.5M–$15M; Series A $9M–$53M; Series B $16M–$107M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Bigscreen — Founded by Darshan Shankar in 2014, Bigscreen is a venture-backed startup creating an immersive virtual reality platform that aims to revolutionize the way people work, play, hangout, and collaborate.Use cases of Bigscreen include both entertainment and productivity. Users love using Bigscreen as a "VR movie theater" to watch movies andTV shows. It's also used to play videogames, browse the web, and hangout with friends. It's can also be used for productivity as a tool for remote teams to collaborate together in virtual offices.Since the beta launch in March 2016, Bigscreen has become one of the most popular and highest rated VR apps on the Oculus Store and has an incredible 93% positive rating on Steam. Power users spend 20-30 hours per week in Bigscreen, making it one of the most widely used "killer apps" in the industry.Bigscreen is now the most popular non-gaming VR application in the world.Bigscreen is a fully distributed remote company with employees based around the world in the US & UK.
- Dapper Labs — Dapper Labs uses the power of play to deliver blockchain-based experiences that are made for you and ready for the real world.
- The Believer Company — Join the journey We are building a world-class team to serve players for years to come. If you believe in games, we believe in you.
Rock Health Capital is a full-service seed fund that invests in and supports startups working in digital health. The company invests in entrepreneurs working at the intersection of healthcare and technology. Rock Health Capital is a digital health-focused investment firm.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark
Investor stats
- Total investments: 115
- Round size: Seed $20k–$4.2M; Series A $4.7M–$34M; Series B $8M–$63M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Burst — Burst | FSA & HSA Checkout, Reimbursements, and LMNs anywhere
- No Barrier —
- Rosarium Health — Rosarium Health is a platform that connects service providers (home contractors and occupational therapists) with customers to execute accessible house assessments and accessible home modifications at a client's primary home, leased property, or company.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 589
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 247
- Round size: Seed $2M–$31M; Series A $12M–$100M; Series B $25M–$150M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- miRecule — MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
- Marvin Health — Marvin is a mental health service for physicians. We're ending the one-size-fits-all approach to teletherapy, helping you to set a teletherapy action plan.
- Deep Genomics — Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 450
- Round size: Series A $4.5M–$80M; Series B $7M–$107M; Series C $10M–$100M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $182M in 1998
Portfolio highlights
- Thirty Madison — Thirty Madison is a human-first healthcare company, powering access to affordable specialized healthcare through brands like Keeps and Cove.
- CliQr Technologies — CliQr is a leading provider of application-defined cloud management solutions. Offering full lifecycle management delivered in a single, intuitive packaged platform, CliQr enables businesses to easily and efficiently model, deploy and manage one to many applications, users, and clouds.CliQr’s application-defined technology de-couplesapplications from the complexity of hybrid cloud environments, allowing them to securely move, deploy and manage new and existing application across any physical, virtual or cloud environment.CliQr’s patented and patent-pending technology and its global partners help dozens of leading brands in healthcare, manufacturing and technology markets manage their cloud application lifecycles in over 15 different data center, private and public cloud environments.Headquartered in San Jose, California, with locations in Canada, India and Czech Republic, CliQr is backed by Polaris Partners, Foundation Capital, Google Ventures and TransLink Capital. For additional information, visit www.cliqr.com.
- Invivyd — Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patientsand clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 251
- Round size: Seed $200k–$5.3M; Series A $2.4M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- NorthPage — NorthPage provides a cloud-based digital marketing optimization platform that enables frictionless performance benchmarking, competitive analysis, and best-practice guidance for enterprise marketing organizations. Its solutions enable optimization of Websites, e-commerce sites, mobile marketing, social media, search engine marketing, contentmarketing, and e-retail programs. The company serves retail, financial services, consumer product, pharmaceutical, and technology companies. NorthPage Inc. was founded in 2007 and is based in Southbury, Connecticut.
- IntelliBoard — The IntelliBoard Learning Analytics Platform helps you retain students, increase their engagement, and manage compliance.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 418
- Round size: Series A $3.2M–$75M; Series B $8M–$115M; Series C $6M–$95M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Judo Bio — Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.
- Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
- Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
First Round is a seed-stage venture firm focused on building a vibrant community of technology entrepreneurs and companies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, India
Investor stats
- Total investments: 801
- Round size: Seed $1.1M–$8.4M; Series A $2.1M–$25M; Series B $7M–$60M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- PullString — PullString, Inc. is leading the field of computer conversation in both text and voice through a combination of design and technology. PullString (formerly ToyTalk) is an entertainment and technology company combining art and science to enable computer conversation with characters.The company's primary product, the PullString Platform, offersa professional authoring environment, hosted AI and machine learning runtime, and integrated conversation analytics to enterprises, agencies, and startups across verticals as diverse as entertainment, customer service, gaming and VR, travel, automotive, health and fitness, finance, human resources, and IoT.With direct support for all major conversational platforms like Facebook Messenger, Amazon Alexa, Skype, Slack, Kik, mobile, and web, the PullString Platform has been used to create award winning experiences like Call of Duty’s Lt Reyes on Messenger, Hello Barbie, and The Winston Show.PullString, founded as ToyTalk in 2011, has raised more than $44 million in funding from Greylock Partners; Charles River Ventures; Khosla Ventures; True Ventures; and First Round Capital.
- &Open — For businesses that gift to give back, share joy, or show they care. All you need is an email.
- Merlin Labs — Merlin is the aviation technology company propelling the future of fully autonomous flight.
Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 521
- Round size: Seed $1.8M–$30M; Series A $7M–$60M; Series B $13M–$150M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $100M in 2007
Portfolio highlights
- Clarifai — Clarifai is the leading Machine Learning, Computer Vision, NLP Platform. Label, train, deploy models on one AI platform for developers & data scientists.
- Primer — Primer makes powerful mission-ready AI software designed to work in your environment, on your data. We help national security teams sift through massive unstructured data sets to find the needle in the haystack, understand and visualize their data, and act collaboratively. Our mission is to empower decisions that can be defended, and acted upon confidently.
- Impulse Space — Economical and nimble last-mile space payload delivery
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BoxGroup is an early stage investment fund focused on technology companies. Contact Us: hello@boxgroup.com
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Mexico, Canada
Investor stats
- Total investments: 538
- Round size: Seed $1.6M–$8.5M; Series A $5.5M–$33M; Series B $19M–$90M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Claim — Claim is a social application that allows users to earn and trade rewards with friends. It also connects friends through their favorite brands and for brands to reward their customers. Its application enables friends to earn cash back, exchange rewards, and redeem together by shopping at their favorite brands.
- David Energy — David Energy is an electricity provider that designs, builds, and manages onsite energy grids. The company empowers buildings with the tools needed to maximize onsite energy and bring transparency to a traditionally opaque, commoditized industry. It provides hands-on expertise and on the ground support, all delivered through its software platform.Founded in 2017, David Energy is headquartered in Brooklyn, New York.
- Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 282
- Round size: Series A $4.7M–$80M; Series B $10M–$105M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Stablix — Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1029
- Round size: Seed $1M–$15M; Series A $5.4M–$88M; Series B $15M–$107M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Smarterer — Individuals and Fortune 500 companies use Smarterer to help close the gap between the skills they have and the skills they need. Their dynamic assessment engine leverages the freshest crowdsourced tests around, to rapidly pinpoint skill level with a credible score. In November 2014, Pluralsight, the global leader in online learning for serioussoftware developers, IT specialists and creative technologists, acquired Smarterer. As the world's largest curated e-learning library for professionals, the company offers instant access to more than 3,500 courses authored by top experts. Smarterer will continue to power crowdsourced assessments for freelancer marketplaces, e-learning providers and enterprise companies anywhere people need to prove their skills to connect with professional opportunities. The Smarterer community has answered over 56 million during 1.7 million test sessions, across hundreds of tests.
- Zest — Give your shoppers the swiftest gifting experience in ecommerce. With Zest, shoppers on your site can send a gift to anybody, anywhere with just a link.
- EpiBiologics — EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 655
- Round size: Series A $5M–$40M; Series B $7.8M–$75M; Series C $7.1M–$55M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $100M in 2024
Portfolio highlights
- Hermeus — Hermeus is developing hypersonic aircraft to connect the world faster than ever before.
- WorkMotion — WorkMotion offers Global HR Solutions to help companies navigate the New Ways of Working. Solutions fully compliant.
- Savvy — Savvy is a software development company that engages in cybersecurity.
SV Angel is a service organization, investing in founders who share these values. They support entrepreneurs in building lasting companies by assisting at key inflection points and leveraging networks to help them propel their businesses forward.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 952
- Round size: Seed $1M–$10M; Series A $2.5M–$35M; Series B $8M–$107M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $29M in 2022
Portfolio highlights
- Cartesia — Cartesia provides real-time multimodal intelligence for all devices. Its objective is to develop the next generation of AI: pervasive, interactive intelligence that operates everywhere.
- Polymarket — Bet on your beliefs
- Vulcan — Vulcan builds AI tools that map U.S. laws and regulations, helping users draft, review, and stay compliant with legal documents.
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Romania
Investor stats
- Total investments: 181
- Round size: Seed $1.2M–$4.3M; Series A $347k–$15M; Series B $9M–$59M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $722k in 2022
Portfolio highlights
- Goalsetter — Goalsetter is a goal-based savings and gifting platform, made just for kids and powered by those who love them. It combines the best of goal-based savings platforms like Digit and Acorns with the best of gift-registries like Zola and Honeyfund, and in so doing, targets the millennial mom with a platform that enables families to contribute to kids’future goals instead of buying them more consumer goods. In turn, Goalsetter becomes a savings vehicle for kids, turning first-time savers into all-the-time savers and giving kids healthy financial habits that will last a lifetime.
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- GrubMarket — GrubMarket develops a website where sellers can offer foods and other items at wholesale prices to customers. It offers products such as organic foods, vegetables, gluten-free foods, snacks, drinks, pantries, home goods, health and beauty products, baby and kids' products, pets, non-GMO foods, paleo foods, cholesterol-free, and no trans-fatfoods.GrubMarket also offers foods from local farms, fisheries, commercial kitchens, certified home kitchens, and restaurants. Mike Xu founded GrubMarket in 2014, with its headquarters in Newark in California with an additional office in San Francisco in California.
Founders Fund is a San Francisco based venture capital firm investing in companies building revolutionary technologies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 783
- Round size: Seed $1.5M–$15M; Series A $5.5M–$43M; Series B $15M–$105M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Citrea — Bitcoin's First ZK Rollup
- Lagrange Labs — Seamlessly interact between chains with cryptographically secured state proofs, not opaque intermediaries.
- Workstream — Workstream is an automated hiring platform that helps companies employing hourly workers. The platform helped Jamba, Chick-fil-A, McDonald's, Dunkin', Applebee's, Auntie Anne's, Cinnabon to increase their bottom line and cost savings.Workstream was founded in 2017 and is headquartered in San Francisco, California, UnitedStates.
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Third Rock Ventures believes in the companies we start and makes significant initial investments, which are frequently supplemented by strategic collaborations, to help our firmsprogress in life-changing medicines, technologies, and diagnostics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 148
- Round size: Series A $17M–$110M; Series B $11M–$150M; Series C $14M–$146M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- CytomX Therapeutics — CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
- Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
- Synnovation Therapeutics — Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, andpatient-focused precision medicine, it builds a diverse pipeline of novel small-molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Grant, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 250
- Round size: Seed $100k–$2.5M; Grant $25k–$1M; Pre-Seed $25k–$900k
- Lead/follow: 65% lead, 35% follow
Portfolio highlights
- Truvelop — Truvelop is an agile and adaptive workforce performance evaluation tool to motivate and retain employees, and improve the health of your organization
- Foretrace — Foretrace provides Continuous Automated Reconnaissance using the same exact tools, techniques, and OSINT as real cyber adversaries. This provides our customers visibility into the attackers view of their digital footprint, as well as that of their subsidiaries, vendors, partners, and/or customers.
- Omni Biosciences — Omni Biosciences is a minority women-owned biotechnology company.
5AM Ventures is a venture capital firm that offers seed- and early-stage investments to its clients. The company’s client portfolio consists of firms in the biopharmaceutical, life sciences, medical technology, and research instrument industries. 5AM Ventures was founded in 2002 by John Diekman and Andrew Schwab and is based in California.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 178
- Round size: Series A $13M–$70M; Series B $16M–$110M; Series C $14M–$100M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $450M in 2022
Portfolio highlights
- Neurogastrx — Neurogastrx, Inc. is a venture-stage biopharmaceutical company developing products for the treatment of gastrointestinal disorders.
- Vor Biopharma — Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. Our goal is to bring life-changing therapies to patients worldwide who are living with serious, autoantibody-driven conditions.
- Cleave Therapeutics — Cleave Therapeutics develops oncology pharmaceuticals designed to target neurodengeneration and pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival, enabling patients to get cured from cancer.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Canada
Investor stats
- Total investments: 118
- Round size: Seed $200k–$2.5M; Series A $3M–$40M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $20M in 2002
Portfolio highlights
- Latus Bio — Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.
- Tolerance Bio — Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi
- Vittoria Biotherapeutics — Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
Powering Breakthroughs in Life Sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 225
- Round size: Series A $9M–$84M; Series B $20M–$125M; Series C $12M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $850M in 2021
Portfolio highlights
- Chiasma — We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare diseases.
- Syndax Pharmaceuticals — Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor.Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
- Portola Pharmaceuticals — As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.
8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies. The firm focuses on creating long-term economic and societal value through its investments across various sectors, including healthcare and logistics.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 481
- Round size: Seed $2.7M–$13M; Series A $7.4M–$55M; Series B $16M–$175M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Raydiant — Raydiant empowers brick-and-mortar organizations to deliver engaging, personalized, and measurable on-screen digital experiences to delight in-store customers and engage back-of-house employees.
- Adentro — Zenreach created Walk-Through Marketing to help businesses with physical locations dramatically improve customer acquisition and lifetime value by connecting digital marketing with in-store results. Zenreach Engage automatically tracks customer visits, effortlessly builds rich customer profiles and keeps them up to date. Zenreach Attract improvesad performance 4x by targeting audiences based on your best customers. Results are measured with our Walk-Through Rate™, a proprietary metric that shows when someone exposed to an ad visits a location. Founded in 2012, Zenreach serves thousands of independent merchants and leading brands like Peet’s Coffee, Ruth’s Chris and BCBG Max Azria.
- Better Health — Better Health is a Modern Medical Supplier focused on delivering Urology & Ostomy Supplies. Shop the latest Catheters, Ostomy Bags from Hollister, Convatec, Coloplast and many more.
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 77
- Round size: Seed $700k–$6M; Series A $1.9M–$16M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely still investing — raised $64M in 2022
Portfolio highlights
- FreeNav, Inc. — FreeNav is simplifying and standardizing the position tracking of procedural instrumentation for medical applications and procedures.
- Hermes Health — Big IdeaHermes Health is a secure, neutral middleware platform that simplifies and standardizes access to identified patient health data. We connect Requestors (e.g., attorneys, CROs, analytics firms) with Partners (e.g., ROI vendors, EHR providers, RWD sources) who hold and manage this data.ProblemAccessing identified health data remainslargely manual and outdated—relying on phone calls, faxes, and mailed records. This process is fragmented, costly, and inefficient. Requestors face a maze of disconnected workflows, while Partners are bogged down by inconsistent standards and manual tasks.SolutionHermes Health offers a scalable API and the Unity Platform to power secure, patient-consented data workflows. We reduce integration complexity and contractual friction by enabling seamless connectivity between Requestors and our network of Partners.The Unity Platform integrates with Partners as they are—plugging into existing APIs or co-developing new ones to match their systems. Whether you're a requestor or a data custodian, Hermes Health accelerates access while preserving security and compliance.
- Esperto Medical — Esperto Medical is an Irvine, CA-based medical device company developing next-generation wearable diagnostics that enable hospital-based and remote patient monitoring with unprecedented ease and accuracy. Its unique resonance sonomanometry technology uses acoustic stimulation to directly and noninvasively measure continuous blood pressure withoutcalibration.
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Post-IPO Equity
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 448
- Round size: Series B $26M–$152M; Series C $40M–$200M; Post-IPO Equity $34M–$235M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Curevo — focused on a new generation of adjuvanted subunit vaccines Learn More Our Focus We're dedicated to developing non-mRNA vaccines for unmet medical needs Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines. We focus on one need at a time, allowing us to bring effective and better-tolerated vaccines to market quickly
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Terrestrial Bio — Vaxess engineers novel technologies that uniquely engage the human immune system, enabling improved efficacy and simplified access for vaccines and therapeutics.
Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada
Investor stats
- Total investments: 94
- Round size: Seed $1M–$3.4M; Series A $1.6M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- S2 Genomics — S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomicanalyses.S2 Genomics was founded in 2016 and is headquartered in Livermore, CA.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
Rev1 Ventures provides seed stage venture capital funding in Columbus, Ohio along with startup services, space, mentoring, and connections. Learn more!
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: United States, Germany
Investor stats
- Total investments: 195
- Round size: Seed $192k–$3.2M; Series A $1.2M–$18M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $20M in 2021
Portfolio highlights
- FinOpsly — Maximize your cloud ROI with FinOpsly. Our AI-driven platform empowers organizations with smart cost management, fostering collaboration across teams for over 32% in savings. Simplify your cloud strategy with FinOpsly.
- InnerActiv — InnerActiv is a cybersecurity software company that protects organizations from insider threats, fraud, and data loss at the endpoint. Built with an AI-driven, behavior-based approach, InnerActiv delivers real-time visibility into how users interact with sensitive data, systems, and devices—detecting risky activity such as data grazing, policytesting, and low-and-slow reconnaissance before it leads to a breach. The platform’s lightweight, encrypted agents and endpoint-first design provide proactive protection, faster response, and seamless integration with existing security stacks.
- Niobium Microsystems — The encrypted cloud has arrived.
Privately Held Companies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Japan
Investor stats
- Total investments: 115
- Round size: Series A $1.9M–$32M; Series B $2.6M–$61M; Series C $5M–$80M
- Lead/follow: 61% lead, 39% follow
- Last fund: Likely still investing — raised $260M in 2021
Portfolio highlights
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
- SONIRE Therapeutics — SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd..
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Founded in 2005, True Ventures is a Silicon Valley-based venture capital firm that invests in early-stage technology startups. With more than $3.8 billion under management, True provides seed and Series A financing to entrepreneurs in some of today's growing markets. With more than 40 team members including special advisors, operationsprofessionals, and founders-turned-investors, True represents one of the largest and most experienced teams dedicated to the ecosystem. The True team believes creativity flourishes when founders are supported fully and empowered to pursue brave ideas. To that end, the True Platform offers programs that inspire professional and personal growth. To date, True has helped more than 350 companies launch and scale their businesses, creating over 85,000 jobs worldwide. True was awarded Venture Firm of the Year by the National Venture Capital Association in 2018. To learn more, visit www.trueventures.com.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 597
- Round size: Seed $1.2M–$9.6M; Series A $2M–$28M; Series B $4M–$50M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Bigscreen — Founded by Darshan Shankar in 2014, Bigscreen is a venture-backed startup creating an immersive virtual reality platform that aims to revolutionize the way people work, play, hangout, and collaborate.Use cases of Bigscreen include both entertainment and productivity. Users love using Bigscreen as a "VR movie theater" to watch movies andTV shows. It's also used to play videogames, browse the web, and hangout with friends. It's can also be used for productivity as a tool for remote teams to collaborate together in virtual offices.Since the beta launch in March 2016, Bigscreen has become one of the most popular and highest rated VR apps on the Oculus Store and has an incredible 93% positive rating on Steam. Power users spend 20-30 hours per week in Bigscreen, making it one of the most widely used "killer apps" in the industry.Bigscreen is now the most popular non-gaming VR application in the world.Bigscreen is a fully distributed remote company with employees based around the world in the US & UK.
- Yousician — Yousician is a fun way to learn the guitar, piano, bass, ukulele or singing. Enjoy thousands of songs with Yousician as your personal music teacher!
- Diligent Robotics — We build robots like Moxi that assist hospital staff with routine activities so they can focus on caring for patients.
KdT Ventures is the standard for early-stage frontier science investing.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, India, Canada
Investor stats
- Total investments: 89
- Round size: Seed $2.6M–$13M; Series A $8.5M–$70M; Series B $25M–$175M
- Lead/follow: 9% lead, 91% follow
- Last fund: Likely still investing — raised $80M in 2022
Portfolio highlights
- Elegen — Skip cloning with the only entirely cell-free DNA synthesis provider. Sequences up to 7 kb. Error rates as low as 1:70,000/bp. Manufactured in USA, NGS-verified and shipped globally in as few business days.
- Checkerspot — A biology-driven platform creating specialized lipids from fermentation
- Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Venture capital and technology investments
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 702
- Round size: Seed $1.5M–$10M; Series A $3.1M–$23M; Series B $6.2M–$79M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $378M in 2023
Portfolio highlights
- Blitsy — Blitsy is where creative people shop online. It aims to provide the best selection, value, inspiration, and online shopping experience for creative people worldwide. It was founded in 2011 and is based in Chicago, Illinois.
- MapAnything — Integrate and leverage location-based data and prioritization in your CRM, using Salesforce maps, to optimize your reps' activities.
- Tetra — InHome makes it easier, faster, and cheaper to buy a new boiler, furnace, or air conditioner replacements for your home in MA. No need to call contractors, have sales visits, wait for quotes, or research products. InHome does it all for you online. Get a free instant quote today for a replacement as soon as the next.
We partner with audacious entrepreneurs building enduring businesses.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series B, Series A, Series C
- Geography: United States, India, Israel
Investor stats
- Total investments: 1210
- Round size: Series A $5M–$34M; Series B $9.8M–$58M; Series C $10M–$100M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $3.9B in 2022
Portfolio highlights
- Finmark — The AP, AR, and spend & expense solution that lets you create and pay bills, manage expenses, control budgets, and get the credit your business/firm needs to grow.
- Unrivaled — A 3v3 league built in collaboration with the biggest stars in women's basketball, co-founded by Napheesa Collier and Breanna Stewart. Launching in January 2025.
- Affirmed Networks — Affirmed's fully virtualized, cloud-native solutions allow operators to transform the economics of deploying and scaling 3G, 4G, 5G, and Wi-Fi mobile services.
Backing founders building iconic companies that transcend boundaries
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 550
- Round size: Seed $1.2M–$15M; Series A $4M–$42M; Series B $10M–$76M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- DataGrail — DataGrail is a data privacy startup that helps businesses navigate the growing array of privacy regulations. It constitutes part of a growing roster of platforms that are capitalizing on privacy regulations, such as GDPR in Europe and CCPA in California, by making it easier for companies to manage, automate, and grow their privacy programs.
- Glencoco — A turnkey platform for both sales people to learn about companies, set meetings and get paid, and for companies to generate low-overhead, measurable, cost-effective outbound pipeline
- Depot — The fastest place to build Docker images.
Pear VC partners with entrepreneurs from day zero to build category-defining companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Brazil, Colombia
Investor stats
- Total investments: 309
- Round size: Seed $2.2M–$8.4M; Pre-Seed $500k–$3.7M; Series A $8M–$35M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — raised $432M in 2023
Portfolio highlights
- Thena — Deliver world class customer experiences right inside Slack and Microsoft Teams with Thena
- Axle Health — Axle Health provides scheduling and workforce management software to help home healthcare and hospice providers improve their clinician productivity.
- Socratix AI — Socratix AI offers autonomous AI agents designed to serve as enterprise-grade fraud and risk analysts.
Great Oaks Venture Capital is a leading early-stage venture capital firm with a mission to support and invest in the most innovative and disruptive startups. Visit our home page to learn more about our portfolio companies, investment approach, and the experienced team behind our success.
Show more...Investment focus
- Industry: E-Commerce, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 339
- Round size: Seed $750k–$5.4M; Series A $3.2M–$15M; Series B $6M–$42M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $40M in 2013
Portfolio highlights
- Kargo — Command your freight.
- LuminosAI — Luminos AI provides software for legal and governance teams to assess and manage AI risk. The platform supports compliance testing, evaluation workflows, and automated reporting across classical, generative, and agentic AI systems.
- SingleStore — SingleStore is a provider of a database for operational analytics and cloud-native applications. It provides global enterprises with an intelligent database that works on any cloud on-premises or as a service runs transactions and analytics at the same time and lets clients promote their business through analytics and combine semi-structured datainto a consolidated big data platform.
At Flare Capital, we do more than simply provide capital for early stage and emerging growth healthcare technology companies.
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Series A, Seed, Series B
- Geography: United States, India
Investor stats
- Total investments: 110
- Round size: Seed $1.8M–$10M; Series A $10M–$30M; Series B $10M–$125M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Author Health — Author Health is a platform that provides comprehensive care and treatment for Medicare Advantage recipients with substance use disorders and severe mental illnesses. The company offers a team-based approach to care, grouping specialized physicians, therapists, nurses, and community health workers to give a mix of in-person and virtual care forpatients who are often disconnected from the traditional healthcare system. Author Health launched from stealth in 2023 with $115 million in funding led by General Atlantic and Flare Capital Partners.
- Vincere Health — Vincere Health is a Techstars-backed health tech company founded at the Harvard Innovation Labs in 2019. They use a combination of intelligent, frequent incentives, objectively verified health data, and health coaching to drive behavior change to solve healthcare's biggest challenges - starting with smoking cessation.
- Hospital for Special Surgery — HSS is the #1 ranked hospital in the US for orthopedics, #4 for rheumatology, and top-ranked in pediatric orthopedics | Locations in NY, NJ, CT, and Florida.
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 129
- Round size: Series A $5.2M–$41M; Series B $5M–$90M; Series C $8M–$88M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Ribometrix — The Next Frontier of Drug Discovery
- Contego Medical — Better Outcomes. Simplified. Neurovascular Peripheral Vascular Neurovascular
- G1 Therapeutics — G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It was founded in 2008 by Drs. Norman Sharpless and Kwok-Kin Wong to capitalize on discoveries made and patented by Dr. Sharpless’ lab at the University of North Carolina at Chapel Hill, and subsequently licensed to G1 Therapeutics. Trilaciclib is an investigationaltherapy designed to improve outcomes for people with cancer who are treated with chemotherapy. G1 is also advancing rintodestrant, a potential best-in-class oral selective estrogen receptor degrader, or SERD, for the treatment of ER+ breast cancer.
AMV is the leading early-stage venture capital firm investing in digital health, technology and life sciences. It has assembled the leading early-stage
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Cyprus, Ireland
Investor stats
- Total investments: 144
- Round size: Seed $500k–$6M; Series A $2.4M–$21M; Series B $5M–$35M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $150M in 2020
Portfolio highlights
- SeeQC — SEEQC is developing the first digital quantum computing platform for businesses. SEEQC combines classical & quantum technologies to address the efficiency, stability & cost issues endemic to quantum computing.
- Outcomes4Me — Outcomes4Me is empowering cancer patients globally with treatment options, medical records, and clinical trials all in one app.
- Autonomize AI — AI That Runs Healthcare. For the Humans Who Make It Work. AI-Native Infrastructure: Rewiring Healthcare Operations for the Next Era.
We are deep tech venture capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 383
- Round size: Seed $1.5M–$10M; Series A $5.7M–$45M; Series B $15M–$130M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $1B in 2023
Portfolio highlights
- ZwitterCo — ZwitterCo is revolutionizing water & wastewater treatment with cutting-edge membrane technology, along with providing sustainable, high-efficiency solutions.
- Jupiter Intelligence — The Trusted Leader in Climate Risk Analytics. Learn about our best-in-science solutions.
- Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
Kleiner Perkins is a venture capital firm specializing in investing in early-stage, growth, and incubation companies. The firm continues that legacy, investing in founders with bold ideas that span industries and continents, partnering with them from inception to IPO and beyond to maximize the potential of their ideas. They also focus on earlycomputer firms using their devices and programming and service companies. It also invests in the digital, life sciences, and healthcare industries.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 1031
- Lead/follow: no public data
Portfolio highlights
- Synthesia — Create AI videos by simply typing in text. Make engaging videos for e-learning, customer onboarding, etc. No need for actors, cameras or audio equipment.
- Biz AI Last — Are you ready to elevate your business efficiency and productivity? Say hello to Biz AI, your intelligent business assistant designed to streamline operations, boost productivity, and give you more time to focus on what matters most – growing your business.
- Hippocratic AI — The First Safety Focused LLM for Healthcare
Health Care VC funding in United States at a glance
Stats across 34k deals from 13k investors.
Access all 13307 VC funds in United States Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 13307 VC funds investing in United States Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!